| 62856-405 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-405-10 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-405-30 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-405-90 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-410 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-410-30 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-410-90 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-455 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |
| 62856-455-10 | These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 | Eisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC |